Ugonin L inhibits osteoclast formation and promotes osteoclast apoptosis by inhibiting the MAPK and NF-κB pathways

Bone loss is a major issue for patients with osteoporosis, arthritis, periodontitis, and bone metastasis; however, anti-resorption drugs used to treat bone loss have been linked to a variety of adverse effects. Helminthostachys zeylanica (L.) Hook, belonging to the family Ophioglossaceae, is commonl...

Full description

Bibliographic Details
Main Authors: Chun-Lin Liu, Trung-Loc Ho, Shuen-Yih Fang, Jeng-Hung Guo, Chih-Ying Wu, Yi-Chin Fong, Chih-Chuang Liaw, Chih-Hsin Tang
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223011903
_version_ 1797686862302674944
author Chun-Lin Liu
Trung-Loc Ho
Shuen-Yih Fang
Jeng-Hung Guo
Chih-Ying Wu
Yi-Chin Fong
Chih-Chuang Liaw
Chih-Hsin Tang
author_facet Chun-Lin Liu
Trung-Loc Ho
Shuen-Yih Fang
Jeng-Hung Guo
Chih-Ying Wu
Yi-Chin Fong
Chih-Chuang Liaw
Chih-Hsin Tang
author_sort Chun-Lin Liu
collection DOAJ
description Bone loss is a major issue for patients with osteoporosis, arthritis, periodontitis, and bone metastasis; however, anti-resorption drugs used to treat bone loss have been linked to a variety of adverse effects. Helminthostachys zeylanica (L.) Hook, belonging to the family Ophioglossaceae, is commonly used in traditional Chinese medicine to treat inflammation and liver problems. In the current study, ugonin L extracted from H. zeylanica was shown to reduce the receptor activator of nuclear factor kappa beta ligand (RANKL)-induced osteoclastogenesis in RAW264.7 cells in a concentration-dependent manner. Ugonin L treatment also inhibited the mRNA expression of osteoclast markers. Ugonin L was also shown to promote cell apoptosis in mature osteoclasts and suppress RANKL-induced ERK, p38, JNK, and NF-κB activation. Taken together, ugonin L appears to be a promising candidate for the development of novel anti-resorption therapies.
first_indexed 2024-03-12T01:10:43Z
format Article
id doaj.art-5efebeddfc8d467ab3f209607e6fab1e
institution Directory Open Access Journal
issn 0753-3322
language English
last_indexed 2024-03-12T01:10:43Z
publishDate 2023-10-01
publisher Elsevier
record_format Article
series Biomedicine & Pharmacotherapy
spelling doaj.art-5efebeddfc8d467ab3f209607e6fab1e2023-09-14T04:52:53ZengElsevierBiomedicine & Pharmacotherapy0753-33222023-10-01166115392Ugonin L inhibits osteoclast formation and promotes osteoclast apoptosis by inhibiting the MAPK and NF-κB pathwaysChun-Lin Liu0Trung-Loc Ho1Shuen-Yih Fang2Jeng-Hung Guo3Chih-Ying Wu4Yi-Chin Fong5Chih-Chuang Liaw6Chih-Hsin Tang7Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan; Department of Neurosurgery, China Medical University Hospital, Taichung, TaiwanGraduate Institute of Biomedical Sciences, China Medical University, Taichung, TaiwanDepartment of Marine Biotechnology and Resources, National Sun Yat-sen University, Kaohsiung, TaiwanGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan; Department of Neurosurgery, China Medical University Hospital, Taichung, TaiwanDepartment of Neurosurgery, China Medical University Hospital, Taichung, Taiwan; Graduate Institute of Integrated Medicine, China Medical University, Taiwan; Department of Neurosurgery, China Medical University Hsinchu Hospital, Hsinchu, TaiwanDepartment of Sports Medicine, College of Health Care, China Medical University, Taichung, Taiwan; Department of Orthopedic Surgery, China Medical University Hospital, Taichung, Taiwan; Department of Orthopedic Surgery, China Medical University Beigang Hospital, Yunlin, TaiwanDepartment of Marine Biotechnology and Resources, National Sun Yat-sen University, Kaohsiung, Taiwan; Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung, Taiwan; Corresponding author at: Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Kaohsiung, Taiwan.Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan; Department of Pharmacology, School of Medicine, China Medical University, Taichung, Taiwan; Chinese Medicine Research Center, China Medical University, Taichung, Taiwan; Department of Medical Laboratory Science and Biotechnology, College of Medical and Health Science, Asia University, Taichung, Taiwan; Department of Medical Research, China Medical University Hsinchu Hospital, Hsinchu, Taiwan; Corresponding author at: Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.Bone loss is a major issue for patients with osteoporosis, arthritis, periodontitis, and bone metastasis; however, anti-resorption drugs used to treat bone loss have been linked to a variety of adverse effects. Helminthostachys zeylanica (L.) Hook, belonging to the family Ophioglossaceae, is commonly used in traditional Chinese medicine to treat inflammation and liver problems. In the current study, ugonin L extracted from H. zeylanica was shown to reduce the receptor activator of nuclear factor kappa beta ligand (RANKL)-induced osteoclastogenesis in RAW264.7 cells in a concentration-dependent manner. Ugonin L treatment also inhibited the mRNA expression of osteoclast markers. Ugonin L was also shown to promote cell apoptosis in mature osteoclasts and suppress RANKL-induced ERK, p38, JNK, and NF-κB activation. Taken together, ugonin L appears to be a promising candidate for the development of novel anti-resorption therapies.http://www.sciencedirect.com/science/article/pii/S0753332223011903Ugonin LOsteoclastRANKLBone resorptionApoptosis
spellingShingle Chun-Lin Liu
Trung-Loc Ho
Shuen-Yih Fang
Jeng-Hung Guo
Chih-Ying Wu
Yi-Chin Fong
Chih-Chuang Liaw
Chih-Hsin Tang
Ugonin L inhibits osteoclast formation and promotes osteoclast apoptosis by inhibiting the MAPK and NF-κB pathways
Biomedicine & Pharmacotherapy
Ugonin L
Osteoclast
RANKL
Bone resorption
Apoptosis
title Ugonin L inhibits osteoclast formation and promotes osteoclast apoptosis by inhibiting the MAPK and NF-κB pathways
title_full Ugonin L inhibits osteoclast formation and promotes osteoclast apoptosis by inhibiting the MAPK and NF-κB pathways
title_fullStr Ugonin L inhibits osteoclast formation and promotes osteoclast apoptosis by inhibiting the MAPK and NF-κB pathways
title_full_unstemmed Ugonin L inhibits osteoclast formation and promotes osteoclast apoptosis by inhibiting the MAPK and NF-κB pathways
title_short Ugonin L inhibits osteoclast formation and promotes osteoclast apoptosis by inhibiting the MAPK and NF-κB pathways
title_sort ugonin l inhibits osteoclast formation and promotes osteoclast apoptosis by inhibiting the mapk and nf κb pathways
topic Ugonin L
Osteoclast
RANKL
Bone resorption
Apoptosis
url http://www.sciencedirect.com/science/article/pii/S0753332223011903
work_keys_str_mv AT chunlinliu ugoninlinhibitsosteoclastformationandpromotesosteoclastapoptosisbyinhibitingthemapkandnfkbpathways
AT trunglocho ugoninlinhibitsosteoclastformationandpromotesosteoclastapoptosisbyinhibitingthemapkandnfkbpathways
AT shuenyihfang ugoninlinhibitsosteoclastformationandpromotesosteoclastapoptosisbyinhibitingthemapkandnfkbpathways
AT jenghungguo ugoninlinhibitsosteoclastformationandpromotesosteoclastapoptosisbyinhibitingthemapkandnfkbpathways
AT chihyingwu ugoninlinhibitsosteoclastformationandpromotesosteoclastapoptosisbyinhibitingthemapkandnfkbpathways
AT yichinfong ugoninlinhibitsosteoclastformationandpromotesosteoclastapoptosisbyinhibitingthemapkandnfkbpathways
AT chihchuangliaw ugoninlinhibitsosteoclastformationandpromotesosteoclastapoptosisbyinhibitingthemapkandnfkbpathways
AT chihhsintang ugoninlinhibitsosteoclastformationandpromotesosteoclastapoptosisbyinhibitingthemapkandnfkbpathways